Ab&b Bio-tech Co., Ltd.js
Clinical trials sponsored by Ab&b Bio-tech Co., Ltd.js, explained in plain language.
-
New shingles vaccine trial aims to protect millions over 40
⭐️ VACCINE ⭐️ OngoingThis study tests a new shingles vaccine in 960 healthy adults aged 40 and older. The goal is to see if it is safe and triggers a strong immune response. Researchers will monitor side effects and measure antibody levels over time. This is an early-stage trial to help develop a bet…
Phase: PHASE1, PHASE2 • Sponsor: Ab&B Bio-tech Co., Ltd.JS • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 17, 2026 12:07 UTC
-
New flu shot for seniors passes first safety check
⭐️ VACCINE ⭐️ OngoingThis early-stage study tested a new flu vaccine with an added booster (adjuvant) in 80 adults aged 65 and older. The main goal was to see if the vaccine is safe and what side effects it might cause. Participants were monitored for reactions right after the shot and for up to a ye…
Phase: PHASE1 • Sponsor: Ab&B Bio-tech Co., Ltd.JS • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 15, 2026 19:08 UTC
-
New flu shot for seniors passes early safety check
⭐️ VACCINE ⭐️ OngoingThis early-stage study tested whether a new quadrivalent influenza vaccine with an adjuvant is safe for adults aged 65 and older. About 80 older adults took part, and researchers monitored them for side effects over 12 months. The goal was to see if the vaccine causes any immedia…
Phase: PHASE1 • Sponsor: Ab&B Bio-tech Co., Ltd.JS • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 15, 2026 19:02 UTC